TScan Therapeutics had a revenue of 3.08M in the quarter ending Jun 30, 2025, with 41.69%. This bring the company's revenue in the last twelve months to 6.96M, Decreased 57.45%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.